Is this you?
Request access for Advanced Cardiovascular using your company work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Intera lens
ICP 5Lift (cardio sample) 1.00Recruit soph 0
Quality Scorecard (1–100)
Overall72Recruit62Ops73Sponsor81Ther74
Performance (observed)
Historical trials
272
Completed
132
Terminated/Withdrawn
45
Completion rate
75%
Active now
90
Phase 2
36
Phase 3
158
Realized enrollment
755,951
First study year
2000
Years active
26
Match confidence
high
Enrollment velocity (inf)
29,075
Therapeutic
Areas
Cardiometabolic (cardiology/endocrinology/hepatology/renal, per ClinicalTrials.gov)
Breadth (conditions)
224
States
Alabama
Recruitment (web observed)
Capability notes
5 active recruiting cardiometabolic trials (ClinicalTrials.gov)
Relationships
Sponsors
Boehringer Ingelheim; Pfizer; Eli Lilly and Company; Novo Nordisk A/S; Amgen; Boston Scientific Corporation
CROs
ABX CRO; ICON plc; IQVIA Biotech; Medpace, Inc.; Micro Medical Solution, Inc.; MicroPort CRM
Owner / parent
Unknown
Capacity & people
Investigators
—
Coordinators
—
Emails
s.forbus.adv@gmail.com
Tech & DCT
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
Surfaced via ClinicalTrials.gov mining (not on curated lists). 5 active recruiting cardiometabolic trials across 1 location(s). Actively-recruiting independent site = warm Intera lead; website/leadership not yet verified.
Recommendation features (sample indication)
Ind fit 1.00Liftability 1.00Overall72
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.